Cyclic adenosine diphosphate-ribose
SIGMA/C7344 - ≥90% (HPLC), lyophilized powder
Synonym: ADP-cyclo[N1:1′′]-ribose; Cyclic ADPR; cADP-ribose; cADPR
CAS Number: 119340-53-3
Empirical Formula (Hill Notation): C15H21N5O13P2
Molecular Weight: 541.30
MDL Number: MFCD00214262
Linear Formula: C15H21N5O13P2
Product Type: Chemical
| assay | ≥90% (HPLC) |
| biological source | ( |
| form | lyophilized powder |
| InChI | 1S/C15H21N5O13P2/c16-12-7 |
| InChI key | BQOHYSXSASDCEA-KEOHHSTQSA |
| Quality Level | 200 ![]() |
| SMILES string | O[C@H]1[C@@H](O)[C@H]2O[C |
| solubility | water: 5 mg/mL, clear, colorless |
| storage temp. | −20°C |
| Application: | Cyclic adenosine diphosphate-ribose ( |
| Application: | Cyclic adenosine diphosphate-ribose has been used to stimulate astrocytes to activate CD38 signaling. It has also been used as a supplement in buffered peptone water to recover S. enteritidis. |
| Biochem/physiol Actions: | Mobilizes intracellular Ca2+; regulates Ca2+-induced Ca2+ release specifically blocked by ryanodine; second messenger for glucose-induced insulin release from the endocrine pancreas and for abscisic acid-induced calcium release in plants. |
| Packaging: | 0.5 mg in glass bottle |
| Packaging: | Package size based on nucleotide content. |
| Physical form: | Lyophilized powder |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 41106305 |


